Herbal Therapeutics in Osteoporosis: Mechanisms, Evidence, and Translational Potential
Phytotherapy Research · 2026-11 · 40 (11) · 6709-6747
DOI: 10.1002/ptr.70457 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Phytotherapy Research, online erschienen am 22.09.2026. Verfasst von Elnaz Vafadar Moradi und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Emergency Medicine, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran. Hauptthemen laut MEDLINE: Osteoporosis, Phytotherapy, Plant Extracts. Die Arbeit nennt 128 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Osteoporosis is a chronic bone disease marked by reduced density and increased fracture risk. Current treatments face limitations in safety, efficacy, and long‐term adherence, prompting interest in alternative therapies. Herbal medicine, with its bioactive compounds and historical use, offers potential for bone health support. This review explores the role of Chrysanthemum morifolium , Crocus sativus , Eriobotrya japonica , Ficus carica , Glycine max , Olea europaea , Salvia rosmarinus , and Zingiber officinale in preventing and managing osteoporosis. Relevant studies were identified through comprehensive searches of Google Scholar, PubMed, Scopus, and Web of Science, without time restriction up to October 2025. Included literature encompassed in vitro experiments, in vivo animal models, and clinical trials investigating herbal interventions targeting bone loss and osteoporosis‐related mechanisms. The reviewed botanicals modulate key molecular pathways involved in bone remodeling, including RANKL/NFATc1, MAPKs, NF‐κB, Sirt1, Nrf2, BMP/Smad, Wnt/β‐catenin, and XPO5–microRNA axes. Their bioactive constituents exert antioxidant, anti‐inflammatory, anti‐apoptotic, anti‐senescent, and hormone‐modulating effects, collectively promoting osteoblast differentiation and suppressing osteoclastogenesis. Several agents, such as crocin, safranal, and ursolic acid, demonstrated dual‐action profiles and favorable safety in preclinical models, with emerging evidence supporting their immunomodulatory and angiogenic roles. Herbal therapeutics offer a multi‐targeted, biologically harmonious approach to osteoporosis management. This review provides a mechanistic synthesis and translational framework for future research, highlighting their potential as adjunctive therapies, especially in aging populations. Standardization, clinical validation, and interdisciplinary collaboration are essential to advance these botanicals from bench to bedside.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Emergency Medicine, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.
- Clinical Research Development Unit, Ghaem Hospital, Mashhad University of Medical Sciences, Mashhad, Iran.
- School of Pharmacy, Mashhad University of Medical Sciences, Mashhad, Iran.
- Pharmacological Research Center of Medicinal Plants, Basic Sciences Research Institute, Mashhad University of Medical Sciences, Mashhad, Iran.
- Shahid Hasheminejad Hospital, Mashhad University of Medical Sciences, Mashhad, Iran.
ORCID-Profile: Elnaz Vafadar Moradi, Mahboobeh Ghasemzadeh Rahbardar
Zitieren
APA
Vafadar Moradi, E., Vossoughinia, S., Yazdanpanah, Z., Sobhani, H., Jalali, J., & Ghasemzadeh Rahbardar, M. (2026). Herbal Therapeutics in Osteoporosis: Mechanisms, Evidence, and Translational Potential. Phytotherapy Research, 40(11), 6709-6747. https://doi.org/10.1002/ptr.70457
Vancouver
Vafadar Moradi E, Vossoughinia S, Yazdanpanah Z, Sobhani H, Jalali J, Ghasemzadeh Rahbardar M. Herbal Therapeutics in Osteoporosis: Mechanisms, Evidence, and Translational Potential. Phytotherapy Research. 2026;40(11):6709-6747. doi:10.1002/ptr.70457
BibTeX
@article{VafadarMoradi2026,
author = {Vafadar Moradi, Elnaz and Vossoughinia, Sina and Yazdanpanah, Zahra and Sobhani, Hossein and Jalali, Jalileh and Ghasemzadeh Rahbardar, Mahboobeh},
title = {Herbal Therapeutics in Osteoporosis: Mechanisms, Evidence, and Translational Potential},
journal = {Phytotherapy Research},
year = {2026},
volume = {40},
number = {11},
pages = {6709--6747},
doi = {10.1002/ptr.70457}
}
EUVIMED